Two cases of superior mesenteric artery syndrome during chemotherapy in patients with lung cancer

• Published in: International cancer conference journal Vol. 11; no. 2; pp. 124 - 128
• Main Authors: Miyadera, Keiki, Nakamichi, Shinji, Miyashita, Ryota, Shimizu, Masamitsu, Noro, Rintaro, Kubota, Kaoru, Seike, Masahiro, Gemma, Akihiko
• Format: Journal Article
• Language: English
• Published: Singapore Springer Singapore 01.04.2022; Springer Nature B.V
• Subjects: Abdomen; Adenocarcinoma; Anorexia; Aorta; Body mass index; Cancer therapies; Case Report; Chemotherapy; Computed tomography; Coronary vessels; Duodenum; Endoscopy; Epidermal growth factor receptors; Inflammatory bowel disease; Lung cancer; Medicine; Medicine & Public Health; Mesothelioma; Nanoparticles; Non-small cell lung carcinoma; Nutrition; Oncology; Paclitaxel; Parenteral nutrition; Patients; Pembrolizumab; Small cell lung carcinoma; Small intestine; Stenosis; Surgical Oncology; Tomography; Veins & arteries; Vomiting; Weight; Superior mesenteric artery syndrome; Chemotherapy; Pembrolizumab; Lung cancer; Nab-paclitaxel; Non-small cell lung cancer

Superior mesenteric artery (SMA) syndrome is a rare disease, characterized by the narrowing of the third portion of the duodenum between the aorta and SMA. The cause of the stenosis is a decrease in retroperitoneal fat between the aorta and SMA. In this report, we present two cases of SMA syndrome t...